New vaccines may use AI to hit a moving target
Can AI create vaccines that work against mutations that haven't happened yet, groups of viruses, and virus too tricky to currently stop?
Door-to-door vaccination campaign reaches the most vulnerable3:20
An equitable door-to-door vaccination campaign might be just what it takes to help the U.S.’s most vulnerable communities fight COVID-19.
CRISPR halts coronavirus transmission in human cells
A new CRISPR treatment that halted coronavirus transmission in human cells could be the easy-to-distribute COVID-19 drug the world needs.
“LEGO-like” vaccine protects mice from COVID, SARS, MERS, and variants
Using a “chimeric” spike protein, researchers have immunized mice against multiple types of coronaviruses with one shot.
Moderna COVID-19 vaccine 2.0: Lower dose, fewer side effects
Any revised version of the Moderna COVID-19 vaccine will likely include a smaller dose, reducing side effects and increasing the supply of shots.
Mass vaccination experiment was a huge success in Brazil
A mass vaccination experiment in Brazil suggests that even a moderately effective vaccine can have a dramatic effect if enough people get the shot.
Inhaled nanobodies treat COVID-19 in hamsters
An inhaled nanobody treatment for COVID-19 has shown promise in animal tests and could be a more affordable alternative to monoclonal antibody drugs.
One-minute COVID-19 breath test authorized in Singapore
Singapore has provisionally authorized a COVID-19 breath test that measures VOCs to deliver accurate results in just one minute.
Inhaled CRISPR treatment tackles COVID-19, flu
An inhaled CRISPR treatment can be easily tweaked to attack a variety of viruses, from the one that causes the flu to the coronavirus behind COVID-19.